Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence

References

• Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233.
   PubMedGoogle Scholar
• Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130:223-33; PMID:17662938; http://dx.doi.org/10.1016/j.cell.2007.07.003.
   PubMed Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24:2463-79; PMID:21078816; http://dx.doi.org/10.1101/gad.1971610.
   PubMed Web of Science ®Google Scholar
• Chandler H, Peters G. Stressing the cell cycle in senescence and aging. Curr Opin Cell Biol 2013; 25:765-71; PMID:23916530; http://dx.doi.org/10.1016/j.ceb.2013.07.005.
   PubMed Web of Science ®Google Scholar
• Munoz-Espin D, Canamero M, Maraver A, Gomez-Lopez G, Contreras J, Murillo-Cuesta S, Rodriguez-Baeza A, Varela-Nieto I, Ruberte J, Collado M, et al. Programmed cell senescence during mammalian embryonic development. Cell 2013; 155:1104-18; PMID:24238962; http://dx.doi.org/10.1016/j.cell.2013.10.019.
   PubMed Web of Science ®Google Scholar
• Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V, Yosef R, Pilpel N, Krizhanovsky V, Sharpe J, et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013; 155:1119-30; PMID:24238961; http://dx.doi.org/10.1016/j.cell.2013.10.041.
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602; PMID:9054499; http://dx.doi.org/10.1016/S0092-8674(00)81902-9.
   PubMed Web of Science ®Google Scholar
• Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52; http://dx.doi.org/10.1126/science.279.5349.349.
   PubMed Web of Science ®Google Scholar
• Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8:279-82; PMID:9501072; http://dx.doi.org/10.1016/S0960-9822(98)70109-5.
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/10.1073/pnas.92.20.9363.
   PubMed Web of Science ®Google Scholar
• Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging cell 2006; 5:187-95; PMID:16626397; http://dx.doi.org/10.1111/j.1474-9726.2006.00199.x.
   PubMed Web of Science ®Google Scholar
• Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998; 12:3008-19; PMID:9765203; http://dx.doi.org/10.1101/gad.12.19.3008.
   PubMed Web of Science ®Google Scholar
• Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211:90-8; PMID:8125163; http://dx.doi.org/10.1006/excr.1994.1063.
   PubMed Web of Science ®Google Scholar
• Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 1996; 93:13742-7; PMID:8943005; http://dx.doi.org/10.1073/pnas.93.24.13742.
   PubMed Web of Science ®Google Scholar
• Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16:859-67; PMID:8622687.
   PubMed Web of Science ®Google Scholar
• Wong H, Riabowol K. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Exp Gerontol 1996; 31:311-25; PMID:8706801; http://dx.doi.org/10.1016/0531-5565(95)00025-9.
   PubMed Web of Science ®Google Scholar
• Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19:2109-17; PMID:10022898.
   PubMed Web of Science ®Google Scholar
• McConnell BB, Starborg M, Brookes S, Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 1998; 8:351-4; PMID:9512419; http://dx.doi.org/10.1016/S0960-9822(98)70137-X.
   PubMed Web of Science ®Google Scholar
• Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196:33-9; PMID:1652450; http://dx.doi.org/10.1016/0014-4827(91)90453-2.
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25; PMID:8242752; http://dx.doi.org/10.1016/0092-8674(93)90500-P.
   PubMed Web of Science ®Google Scholar
• Koh J, Enders GH, Dynlacht BD, Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 1995; 375:506-10; PMID:7777061; http://dx.doi.org/10.1038/375506a0.
   PubMed Web of Science ®Google Scholar
• Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995; 375:503-6; PMID:7777060; http://dx.doi.org/10.1038/375503a0.
   PubMed Web of Science ®Google Scholar
• Medema RH, Herrera RE, Lam F, Weinberg RA. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A 1995; 92:6289-93; PMID:7603984; http://dx.doi.org/10.1073/pnas.92.14.6289.
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12; PMID:10385618; http://dx.doi.org/10.1101/gad.13.12.1501.
   PubMed Web of Science ®Google Scholar
• Pei XH, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 2005; 24:2787-95; PMID:15838515; http://dx.doi.org/10.1038/sj.onc.1208611.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Kuppuswamy D, Li Y, Livanos EM, Hixon M, White A, Beach D, Tlsty TD. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol 1996; 70:999-1008; PMID:8551641.
   PubMed Web of Science ®Google Scholar
• Jiang H, Chou HS, Zhu L. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression. Mol Cell Biol 1998; 18:5284-90; PMID:9710613.
   PubMed Web of Science ®Google Scholar
• McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol 1999; 19:1981-9; PMID:10022885.
   PubMed Web of Science ®Google Scholar
• Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol Cell Biol 1999; 19:3916-28; PMID:10207115.
   PubMed Web of Science ®Google Scholar
• Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1. Exp Cell Res 1999; 253:503-10; PMID:10585273; http://dx.doi.org/10.1006/excr.1999.4698.
   PubMed Web of Science ®Google Scholar
• Parry D, Mahony D, Wills K, Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999; 19:1775-83; PMID:10022865.
   PubMed Web of Science ®Google Scholar
• Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. Embo J 1996; 15:7060-9; PMID:9003781.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley L, Harper JW, Goodrich DW. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 1997; 8:287-301; PMID:9190208; http://dx.doi.org/10.1091/mbc.8.2.287.
   PubMed Web of Science ®Google Scholar
• Zarkowska T, Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 1997; 272:12738-46; PMID:9139732; http://dx.doi.org/10.1074/jbc.272.19.12738.
   PubMed Web of Science ®Google Scholar
• Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998; 18:753-61; PMID:9447971.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999; 98:859-69; PMID:10499802; http://dx.doi.org/10.1016/S0092-8674(00)81519-6.
   PubMed Web of Science ®Google Scholar
• Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A 1993; 90:11034-8; PMID:8248208; http://dx.doi.org/10.1073/pnas.90.23.11034.
   PubMed Web of Science ®Google Scholar
• Ruas M, Gregory F, Jones R, Poolman R, Starborg M, Rowe J, Brookes S, Peters G. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol 2007; 27:4273-82; PMID:17420273; http://dx.doi.org/10.1128/MCB.02286-06.
   PubMed Web of Science ®Google Scholar
• LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11:847-62; PMID:9106657; http://dx.doi.org/10.1101/gad.11.7.847.
   PubMed Web of Science ®Google Scholar
• Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J 1999; 18:1571-83; PMID:10075928; http://dx.doi.org/10.1093/emboj/18.6.1571.
   PubMed Web of Science ®Google Scholar
• Bagui TK, Jackson RJ, Agrawal D, Pledger WJ. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol 2000; 20:8748-57; PMID:11073976; http://dx.doi.org/10.1128/MCB.20.23.8748-8757.2000.
   PubMed Web of Science ®Google Scholar
• Bagui TK, Mohapatra S, Haura E, Pledger WJ. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol Cell Biol 2003; 23:7285-90; PMID:14517297; http://dx.doi.org/10.1128/MCB.23.20.7285-7290.2003.
   PubMed Web of Science ®Google Scholar
• Olashaw N, Bagui TK, Pledger WJ. Cell cycle control: a complex issue. Cell Cycle 2004; 3:263-4; PMID:14726706; http://dx.doi.org/10.4161/cc.3.3.720.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Martin N, Wilks DP, Tamai K, Huot TJ, Pantoja C, Okumura K, Serrano M, Hara E. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Oncogene 2002; 21:8067-74; PMID:12444543; http://dx.doi.org/10.1038/sj.onc.1206019.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang H, Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993; 7:1572-83; PMID:8101826; http://dx.doi.org/10.1101/gad.7.8.1572.
   PubMed Web of Science ®Google Scholar
• Parry D, Bates S, Mann DJ, Peters G. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. Embo J 1995; 14:503-11; PMID:7859739.
   PubMed Web of Science ®Google Scholar
• Ide T, Tsuji Y, Nakashima T, Ishibashi S. Progress of aging in human diploid cells transformed with a tsA mutant of simian virus 40. Exp Cell Res 1984; 150:321-8; PMID:6319164; http://dx.doi.org/10.1016/0014-4827(84)90575-5.
   PubMed Web of Science ®Google Scholar
• Tsuyama N, Miura M, Kitahira M, Ishibashi S, Ide T. SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblasts. Cell Struct Funct 1991; 16:55-62; PMID:1851674; http://dx.doi.org/10.1247/csf.16.55.
   PubMed Web of Science ®Google Scholar
• Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004; 428:431-7; PMID:15042092; http://dx.doi.org/10.1038/nature02371.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, Hara E. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 2006; 8:1291-7; PMID:17028578; http://dx.doi.org/10.1038/ncb1491.
   PubMed Web of Science ®Google Scholar
• Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, Kaplunov JM, Bucci G, Dobreva M, Matti V, Beausejour CM, et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 2012; 14:355-65; PMID:22426077; http://dx.doi.org/10.1038/ncb2466.
   PubMed Web of Science ®Google Scholar
• Hewitt G, Jurk D, Marques FD, Correia-Melo C, Hardy T, Gackowska A, Anderson R, Taschuk M, Mann J, Passos JF. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012; 3:708; PMID:22426229; http://dx.doi.org/10.1038/ncomms1708.
   PubMed Web of Science ®Google Scholar
• Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E, Albassam M, Zheng X, Leopold WR, Pryer NK, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 2004; 3:1427-38; PMID:15542782.
   PubMed Web of Science ®Google Scholar
• Lane DP, Simanis V, Bartsch R, Yewdell J, Gannon J, Mole S. Cellular targets for SV40 large T-antigen. Proc R Soc Lond B Biol Sci 1985; 226:25-42; http://dx.doi.org/10.1098/rspb.1985.0077.
   PubMed Web of Science ®Google Scholar
• Pemberton H, Anderton E, Patel H, Brookes S, Chandler H, Palermo R, Stock J, Rodriguez-Niedenfuhr M, Racek T, de Breed L, et al. Genome-wide co-localization of Polycomb orthologs and their effects on gene expression in human fibroblasts. Genome Biol 2014; 15:R23; PMID:24485159; http://dx.doi.org/10.1186/gb-2014-15-2-r23.
   PubMed Web of Science ®Google Scholar
• Gagrica S, Brookes S, Anderton E, Rowe J, Peters G. Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence. Cancer Res 2012; 72:165-75; PMID:22080569; http://dx.doi.org/10.1158/0008-5472.CAN-11-2552.
   PubMed Web of Science ®Google Scholar
• Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7:812-21; PMID:8491378; http://dx.doi.org/10.1101/gad.7.5.812.
   PubMed Web of Science ®Google Scholar
• Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499-511; PMID:9832503; http://dx.doi.org/10.1101/gad.12.22.3499.
   PubMed Web of Science ®Google Scholar
• Alt JR, Gladden AB, Diehl JA. p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 2002; 277:8517-23; PMID:11751903; http://dx.doi.org/10.1074/jbc.M108867200.
   PubMed Web of Science ®Google Scholar
• Ide T, Tsuji Y, Ishibashi S, Mitsui Y. Reinitiation of host DNA synthesis in senescent human diploid cells by infection with Simian virus 40. Exp Cell Res 1983; 143:343-9; PMID:6299766; http://dx.doi.org/10.1016/0014-4827(83)90060-5.
   PubMed Web of Science ®Google Scholar
• Gorman SD, Cristofalo VJ. Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI-38 cells by simian virus 40 infection. J Cell Physiol 1985; 125:122-6; PMID:2995423; http://dx.doi.org/10.1002/jcp.1041250116.
   PubMed Web of Science ®Google Scholar
• Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. Embo J 2003; 22:4212-22; PMID:12912919; http://dx.doi.org/10.1093/emboj/cdg417.
   PubMed Web of Science ®Google Scholar
• Leontieva OV, Blagosklonny MV. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion. Cell Cycle 2013; 12:3063-9; PMID:23974099; http://dx.doi.org/10.4161/cc.26130.
   PubMed Web of Science ®Google Scholar
• Imai Y, Takahashi A, Hanyu A, Hori S, Sato S, Naka K, Hirao A, Ohtani N, Hara E. Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch. Cell Rep 2014; 7:194-207; PMID:24703840; http://dx.doi.org/10.1016/j.celrep.2014.03.006.
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Geroconversion: irreversible step to cellular senescence. Cell Cycle 2014; 13:3628-35; PMID:25483060; http://dx.doi.org/10.4161/15384101.2014.985507.
   PubMed Web of Science ®Google Scholar
• Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16; PMID:12809602; http://dx.doi.org/10.1016/S0092-8674(03)00401-X.
   PubMed Web of Science ®Google Scholar
• Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, Dickins RA, Narita M, Zhang M, Lowe SW. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer cell 2010; 17:376-87; PMID:20385362; http://dx.doi.org/10.1016/j.ccr.2010.01.023.
   PubMed Web of Science ®Google Scholar
• Humbert N, Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, Martinez D, Abbadie C, Carling D, de Launoit Y, et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J 2010; 29:376-86; PMID:19927127; http://dx.doi.org/10.1038/emboj.2009.342.
   PubMed Web of Science ®Google Scholar
• Holland EC, Hively WP, Gallo V, Varmus HE. Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. Genes Dev 1998; 12:3644-9; PMID:9851971; http://dx.doi.org/10.1101/gad.12.23.3644.
   PubMed Web of Science ®Google Scholar
• Hitomi M, Stacey DW. Cyclin D1 production in cycling cells depends on ras in a cell-cycle-specific manner. Curr Biol 1999; 9:1075-84; PMID:10531005; http://dx.doi.org/10.1016/S0960-9822(99)80476-X.
   PubMed Web of Science ®Google Scholar
• Gabrielli BG, Sarcevic B, Sinnamon J, Walker G, Castellano M, Wang XQ, Ellem KA. A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay. J Biol Chem 1999; 274:13961-9; PMID:10318807; http://dx.doi.org/10.1074/jbc.274.20.13961.
   PubMed Web of Science ®Google Scholar
• Burgess A, Wigan M, Giles N, Depinto W, Gillespie P, Stevens F, Gabrielli B. Inhibition of S/G2 phase CDK4 reduces mitotic fidelity. J Biol Chem 2006; 281:9987-95; PMID:16476733; http://dx.doi.org/10.1074/jbc.M512714200.
   PubMed Web of Science ®Google Scholar
• Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997; 272:10882-94; PMID:9099745; http://dx.doi.org/10.1074/jbc.272.16.10882.
   PubMed Web of Science ®Google Scholar
• Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004; 430:226-31; PMID:15241418; http://dx.doi.org/10.1038/nature02650.
   PubMed Web of Science ®Google Scholar
• Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, Chick JM, Zhai H, Vidal M, Gygi SP, Braun P, et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer cell 2011; 20:620-34; PMID:22094256; http://dx.doi.org/10.1016/j.ccr.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Wierstra I, Alves J. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4. Biol Chem 2006; 387:949-62; PMID:16913845.
   PubMed Web of Science ®Google Scholar
• Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 1994; 9:1633-40; PMID:8183557.
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5; http://dx.doi.org/10.1126/science.7605428.
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550-3; http://dx.doi.org/10.1126/science.1068999.
   PubMed Web of Science ®Google Scholar